Purchase Order 75N92E19P00115

<p>The National Human Genome Research Institute awarded a purchase order to Covaris, LLC valued at $24,790 on September 1, 2017, for genomic research equipment and related supplies. Place of performance is North Bethesda, Maryland. The order carries firm-fixed pricing with an ultimate completion date of September 30, 2017. No set-aside was applied.</p>

The National Human Genome Research Institute awarded a purchase order to Covaris, LLC valued at $21,833.00 on July 13, 2018, for genomic research equipment and technologies. Performance is located in North Bethesda, Maryland, with an ultimate completion date of August 12, 2018. The order is firm fixed price with no small business set-aside designation. Covaris manufactures specialized laboratory instrumentation including focused ultrasonicator instruments and associated accessories for DNA and...

<p>The National Human Genome Research Institute awarded a purchase order to Covaris, LLC for $6,375.00 on June 18, 2018. The order is firm fixed price with no set-aside designation and an ultimate completion date of January 1, 2019. Place of performance is North Bethesda, Maryland. The source does not specify the items or services being procured.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Covaris, LLC valued at $21,480 on July 12, 2018. Work is performed at North Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of August 11, 2018. No set-aside applies.</p>

The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $19,474 purchase order to Covaris, Inc. Covaris LLC Division of Woburn, Massachusetts. This firm fixed price contract is to provide 01-96 AFA-TUBE TPX PLATE products and services from August 1, 2023 through October 1, 2023 in support of the agency's genomic research initiatives. As the prime contractor, Covaris will deliver the requested items to aid the National Human...

The National Human Genome Research Institute awarded a purchase order to Covaris, LLC for a one-year service plan covering LE220-PLUS equipment (serial number 3388 and WCS 5177) with a ceiling value of $17,255.00, awarded May 7, 2020, with performance through July 1, 2021. Place of performance is Woburn, Massachusetts. The order is firm-fixed-price with no set-aside designation. Covaris is a small business concern specializing in genomic research instrumentation and associated maintenance and...

Covaris, LLC, a Woburn, Massachusetts-based small business specializing in advanced genomic research equipment, was awarded a $17,346 firm-fixed-price purchase order by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health. The contract, issued on December 22, 2025, carries an ultimate completion date of December 21, 2026, and involves no set-aside designation. Covaris is a well-established manufacturer of ultrasonicator instruments utilizing...

<p>The National Human Genome Research Institute awarded a purchase order to Covaris, LLC for maintenance on a flow system, valued at $15,255.36, with an award date of June 17, 2013. Performance occurs in North Bethesda, Maryland, and the contract carries a firm fixed price structure with an ultimate completion date of August 18, 2014. No set-aside was applied.</p>

Covaris, Inc. was awarded a $21,200 purchase order by the Department of Health and Human Services' National Institutes of Health's National Human Genome Research Institute to provide a one-year service plan for a LE220 instrument located in Woburn, Massachusetts. The service plan, valued at $21,200, covers the period of July 1, 2023 through July 1, 2024 and includes quarterly payments for maintenance and support of the LE220 with serial number 3388. No subcontractors or set aside designations...

<p>The NIH Clinical Center awarded a purchase order to Covaris, LLC for $24,015.00 on August 15, 2018, for firm-fixed-price delivery of genomic research equipment and accessories. Work is performed at the awardee's facility in Woburn, Massachusetts. The order carried no set-aside designation and was completed by August 15, 2018.</p>